Crispr Therapeutics shares owned by Hennion & Walsh Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hennion & Walsh Asset Management
from 13F filings
Historical chart of Hennion & Walsh Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Hennion & Walsh Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6M | 24k | 64.81 |
| 2025-06-30 | $1.2M | 24k | 48.64 |
| 2025-03-31 | $1.4M | 40k | 34.03 |
| 2024-12-31 | $1.7M | 44k | 39.36 |
| 2024-09-30 | $1.9M | 41k | 46.98 |
| 2024-06-30 | $1.9M | 35k | 54.01 |
| 2024-03-31 | $1.2M | 17k | 68.16 |
| 2023-12-31 | $1.0M | 17k | 62.60 |
| 2023-09-30 | $695k | 15k | 45.39 |
| 2023-06-30 | $454k | 8.1k | 56.19 |
More positions owned by Hennion & Walsh Asset Management
View all positions for Hennion & Walsh Asset Management